IL2 and infection: However, our results suggest that patients treated with low-dose IL2 may not be at an increased risk of hematogenously spread S. aureus arthritis, but on the contrary, an infection might have a milder course, and that the addition of low-dose IL2 to antibiotics in S. aureus infections might prove beneficial if provided very early.